Genective is a 50/50 joint venture between Limagrain and KWS, two of the world's largest seed companies. With entities and activities in North America, South America, Europe, and Asia, Genective is currently dedicated to the research, development, and commercialization of transgenic traits.
Mineralys Therapeutics
3 followers
MapLight Therapeutics
3 followers
Bionova Scientific
2 followers
Immunic Therapeutics
1 follower
MedRhythms
1 follower
Strand Therapeutics
3 followers
MBX Biosciences
2 followers
Arc Institute
4 followers
Dren Bio
1 follower
Trevi Therapeutics
1 follower
Sitero
2 followers
Thermo Fisher Scientific
286 followers